PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27372977-1	2016	Raltegravir, maraviroc show promise as PrEP drugs in studies.	Raltegravir Potassium	0-11	prolyl endopeptidase	Homo sapiens	39-43	
33842153-5	2021	PEP medications, in particular raltegravir, are known to have a common side effect of insomnia.	Raltegravir Potassium	31-42	prolyl endopeptidase	Homo sapiens	0-3	
26559816-9	2015	Seventy-eight percent (n = 2772) of patients received a prescription for PEP, consisting of Tenofovir/Emtracitabine (TVD) + Lopinavir/Ritonavir (LPV) in 74% of cases, followed by Zidovudine/Lamivudine (CBV) + LPV (10%) and TVD + Raltegravir (RAL) (8%).	Raltegravir Potassium	229-240	prolyl endopeptidase	Homo sapiens	73-76	
26559816-9	2015	Seventy-eight percent (n = 2772) of patients received a prescription for PEP, consisting of Tenofovir/Emtracitabine (TVD) + Lopinavir/Ritonavir (LPV) in 74% of cases, followed by Zidovudine/Lamivudine (CBV) + LPV (10%) and TVD + Raltegravir (RAL) (8%).	Raltegravir Potassium	242-245	prolyl endopeptidase	Homo sapiens	73-76